|
|
||||||||
1 Department of Molecular, Cellular, and Developmental Biology and 2 Life Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109-1048, USA
Reprint requests to: Zhaohui Xu, Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA; e-mail: zhaohui{at}umich.edu; fax: (734) 763-6492.
(RECEIVED March 16, 2005; FINAL REVISION April 25, 2005; ACCEPTED April 25, 2005)
| Abstract |
|---|
|
|
|---|
-helix. In both conformations, the second cysteine residue of the CACA motif is surface-exposed, which contrasts with wildtype thioredoxin where the second cysteine of the CXXC motif is buried. This exposure of a pair of vicinal cysteine residues apparently allows thioredoxin to acquire an ironsulfur cofactor at its active site, and thus a new activity and mechanism of action. Keywords: thioredoxin; ironsulfur cluster; crystal structure; disulfide bond; periplasm
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.051464705.
| Introduction |
|---|
|
|
|---|
Recently, we designed a new pathway for the formation of disulfide bonds in the periplasm that completely bypasses the need for both DsbA and DsbB (Fig. 1
) (Masip et al. 2004). By imposing evolutionary pressure, we isolated mutants of E. coli thioredoxin (TrxA) that can catalyze oxidative protein folding in the bacterial periplasm independently of the action of DsbA and DsbB (Masip et al. 2004). TrxA is a small monomeric protein that has a CXXC catalytic motif (CGPC) and a thioredoxin fold, like DsbA. In contrast to DsbA, however, TrxA catalyzes disulfide bond reduction and it does so in the cytoplasm, not the periplasm. Formation of disulfide bonds by the TrxA mutants represents a reversal of the physiological action of this protein. The hallmark of the isolated mutants is the presence of a third cysteine in the catalytic site of the protein, replacing the CXXC motif with CXCC. We characterized the TrxA mutants that could rescue disulfide bond formation and showed that they are dramatically different from the wild-type thioredoxin: They are dimeric proteins bridged by a [2Fe-2S] ironsulfur cluster. We also showed that the first and the second cysteine residues of the CXCC motif are involved in cluster coordination: A TrxA mutant with a CACA active site sequence [TrxA(CACA)] is also a dimeric protein bridged by an ironsulfur cluster.
|
The structure of the TrxA(CACA) has been solved at 2.3 Å resolution. The mutant protein crystallized as a disulfide-linked dimer, each monomer had an active site that was present in a different conformation. In one of them, the replacement of the CGPC motif by CACA has a dramatic effect on the structure and causes the unraveling of an extended
-helix. In both conformations, the second cysteine residue of the CACA motif is surface- exposed. Based on this structure, we propose a model for the formation of an ironsulfur cluster in this novel thioredoxin.
| Results |
|---|
|
|
|---|
|
-sheet with five parallel and anti-parallel
-strands, surrounded by four
-helices. There are four molecules (A, B, C, D) of TrxA(CACA) per asymmetric unit. These four TrxA (CACA) molecules are arranged as two dimers. One dimer is made up of chains A and B and the other of chains C and D. In each dimer, both chains have nearly identical structures except in the active site (see below). The first two residues of all four molecules are missing and assumed to be disordered.
The second
-helix crystallized in two different conformations
The active site of TrxA is located at the beginning of a long
-helix (helix B), which extends from residue 32 to residue 49 (Fig. 2
). This
-helix is somewhat kinked due to the presence of a proline at residue 40. In molecules A and D, the structure of this region resembles that of the catalytic site of wild-type TrxA (conformation 1). In molecules B and C, however, we observe a dramatic modification of the structure: The first helical turn (3235) of the helix B completely unravels to adopt an extended conformation while the ensuing helical turn (3540) unbends itself at the level of Pro40 (conformation 2). As a result, helix B is no longer kinked. This conformational change causes Cys34 to swing out in the catalytic site.
|
7.5 and 9.2) depending on the protonated state of another residue, Asp26 (Chivers et al. 1997). When Asp26 is protonated, Cys32 has a relatively low pKa of 7.5 and is essentially present as a thiolate at physiological conditions. The deprotonation of Cys32 and its location on the surface of the protein allows this residue to perform a nucleophilic attack on a wide variety of substrates, which results in the formation of a mixed-disulfide. The mixed-disulfide is resolved by attack of the second cysteine residue of the CXXC motif (Cys35), which leads to the formation of a disulfide bond between Cys32 and Cys35. In the wildtype protein, Cys35 is buried in the protein structure and kept protonated. It is activated by general base catalysis by Asp26. To determine the location of the two cysteines (Cys32 and Cys34) in TrxA (CACA), we computed the surface of the mutant protein using Pymol (Delano Scientific). In contrast to the situation in the wild-type protein, both active site cysteines are surfaceexposed in the mutant (Fig. 3
|
|
Many interactions are present at the dimer interface. As shown in Figure 4B
, most of them involve hydrophobic residues. Several backbone atom hydrogen bonds also contribute to the interface. For the dimer constituted of chains A and B, this includes interactions between the amide of IleA75 to the carbonyl of TrpB31, the amide of IleB75 to the carbonyl of TrpA31, the amide of AlaA33 to the carbonyl of IleB75, the amide of AlaB33 to the carbonyl of IleA75, and finally the amide of AlaA93 to the carbonyl of AlaB33 (the symmetry related hydrogen bond between AlaB93 and AlaB33 is lost due to the disulfide bond formation breaking the symmetry).
| Discussion |
|---|
|
|
|---|
-helix that contains the catalytic site (helix B) and is responsible for introducing a kink in this helix, is replaced by a serine (Nikkola et al. 1993; Rudresh et al. 2002). Interestingly, the elimination of this proline did not affect the overall structure of the helix, which remained kinked. In contrast, the catalytic site of TrxA (CACA) presents some striking differences with the wildtype TrxA. First, it is the first time that TrxA crystallized as a dimer with the catalytic site being the dimer interface. Second, the two cysteine residues at the catalytic site are surface-exposed, which allows them to participate in either ironsulfur cluster or disulfide bond formation. Finally, in chains B and C, helix B has unraveled, resulting in the alteration of the catalytic site structure. This change in the structure is likely to be a consequence of the mutations introduced at the catalytic site. However, we cannot rule out the possibility that the formation of an intermolecular disulfide bond strained the structure and caused the unraveling of the helix.
Why is an ironsulfur cluster introduced into TrxA(CACA)?
The replacement of two amino acids in the catalytic site of TrxA changed thioredoxin into a dimeric protein bridged by a [2Fe-2S] ironsulfur cluster. Ironsulfur clusters are usually assembled on selected proteins by complex machinery, but they can also form spontaneously. In both cases, four accessible cysteine residues are required for coordination of the cluster. We propose that the presence of two cysteine residues (Cys32 and Cys34) on the surface of the mutant protein is key to the assembly of an ironsulfur cluster in thioredoxin. However, it is not enough to have solvent exposed cysteines. These cysteines must also be spatially proximate to allow cluster coordination. Therefore, one has to assume that TrxA can form weak dimer in vivo. Formation of a dimer has been reported for one TrxA mutant (Schultz et al. 1999) but not to our knowledge for the wild-type protein.
Both the extent and the nature of the contacts taking place at the dimer interface reinforce the hypothesis of dimer formation by TrxA. As explained above, the size of the contact area and the percentage of hydrophobic residues present at the interface are within the range of what is observed for biological dimer. In fact, most of the residues involved in these contacts have already been proposed to be part of a substrate-binding area by Eklund and coworkers (Eklund et al. 1984). We propose therefore that the residues that are involved in substrate binding by TrxA might also serve to dimerize TrxA in vivo. We cannot exclude the possibility that the formation of some of the interactions present in our structure might be the result of the conformational change observed in chains B and C. For this reason, the dimers formed by TrxA could differ from the dimers formed by TrxA(CACA). However, the requirement to bring the four cysteine residues together to coordinate the ironsulfur cluster strongly suggests that, in both cases, the catalytic site serves as the dimer interface.
A model for the formation of an ironsulfur cluster in TrxA(CACA)
We propose that monomeric TrxA is in equilibrium with dimeric TrxA in vivo (Fig. 5
). In the case of TrxA (CACA), dimer formation brings Cys32 and Cys34 of one subunit in close proximity to Cys32 and Cys34 of a second one. The proximity of these four cysteine residues allows the coordination of an ironsulfur cluster. This cluster either assembles spontaneously or is introduced by the ironsulfur cluster machinery. Our structure suggests that the [2Fe-2S] cluster can be fit into the four-cysteine dimer interface with only minor conformational adjustment.
|
| Materials and methods |
|---|
|
|
|---|
After gel filtration, TrxA(CACA) was incubated with thrombin overnight at 4°C to cleave off the His-tag sequence. The digestion mixture was then loaded onto a second Hi-Trap Ni++-affinity column to purify away the cleaved His-tag and uncleaved protein. The flow-through from this column was then concentrated, desalted as described above, and applied onto a Q-Sepharose Hi-trap column. The column was washed with 25 mL of buffer B (sodium phosphate 25 mM [pH 8]) and protein was eluted with a NaCl gradient (0400 mM in 100 mL of buffer B).
Protein crystallization and data collection
Diffraction quality crystals of TrxA(CACA) were grown by the sitting drop method. The protein was crystallized at 25 mg/mL in 30%PEG 4000, 0.1MTris (pH 8.5), 0.2MMgCl2, 4% acetonitrile at 4°C. Long, plate-like crystals grew in 12 wk. Crystals were cryoprotected by immersion for 1 min in 35% PEG 4000, 0.1MMgCl2, 0.1MTris (pH 8.5), and 4% acetonitrile, followed by flash cooling in liquid nitrogen. The crystals belonged to the monoclinic space group P21 and had unit cell dimensions a=34.7 Å, b=46.3 Å, c=126.0 Å,
=93.1 Å, and contained four molecules of TrxA per asymmetric unit. A 2.3 Å data set was collected at the DND-CAT beamline 5-ID at the Advanced Photon Source. Data were processed with DENZO and SCALEPACK (Otwinowski and Minor 1997).
Structure determination
Initial phases were obtained through the molecular replacement method using the wild-type thioredoxin as a starting model. Four monomers were placed using the program MOLREP from the CCP4 package (Vagin and Teplyakov 2000). All subsequent refinement was performed in CNS with all of the data from 452.3 Å, with bulk solvent correction, and with progressmeasured using cross-validation (free R-factor calculation) with a 5% randomly selected test set (Brunger et al. 1998). Initial refinement consisted of rigid body refinement to better place the four monomers, which were then used to generate the non-crystallographic symmetry (NCS) relationships between the monomers. Several cycles of refinement then proceeded with strict NCS imposed on all four molecules. One cycle of refinement consisted of conjugated gradient minimization, grouped B-factor refinement, torsion angle dynamics simulated annealing using the maximum likelihood target function (MLF), followed by model rebuilding in O (Jones et al. 1991). Over the course of refinement, it was realized that the four molecules in the asymmetric unit adopt two substantially different conformations at the catalytic sites. Therefore, the NCS constraints were reduced to restraints between conformationally distinct molecules in the later rounds of refinement. In the final rounds, individual atomic B-factors for the model were refined with no NCS restraints imposed between conformationally distinct molecules and weak restraints between conformationally-identical molecules. The coordinates and structure factors have been deposited into the Protein Data Bank (PDB ID code 1ZCP).
| Footnotes |
|---|
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
Bardwell, J.C., McGovern, K., and Beckwith, J. 1991. Identification of a protein required for disulfide bond formation in vivo. Cell 67: 581589.[CrossRef][Medline]
Brunger, A.T., Adams, P.D., Clore, G.M., Delano, W.L., Gros, P., Grosse- Kunstleve, R.W., Jiang, J.-S., Kuszewski, J., Nilges, N., Pannu, N.S., et al. 1998. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Cryst. D Biol. Crystallogr. 54: 905921.
Chivers, P.T., Prehoda, K.E., Volkman, B.F., Kim, B.M., Markley, J.L., and Raines, R.T. 1997. Microscopic pKa values of Escherichia coli thioredoxin. Biochemistry 36: 1498514991.[CrossRef][Medline]
Collet, J.F. and Bardwell, J.C. 2002. Oxidative protein folding in bacteria. Mol. Microbiol. 44: 18.[CrossRef][Medline]
Dailey, F.E. and Berg, H.C. 1993. Mutants in disulfide bond formation that disrupt flagellar assembly in Escherichia coli. Proc. Natl. Acad. Sci. 90: 10431047.
Eklund, H., Cambillau, C., Sjoberg, B.M., Holmgren, A., Jornvall, H., Hoog, J.O., and Branden, C.I. 1984. Conformational and functional similarities between glutaredoxin and thioredoxins. EMBO J. 3: 14431449.[Medline]
Holmgren, A., Soderberg, B.O., Eklund, H., and Branden, C.I. 1975. Three-dimensional structure of Escherichia coli thioredoxin-S2 to 2.8 Å resolution. Proc. Natl. Acad. Sci. 72: 23052309.
Janin, J. and Chothia, C. 1990. The structure of proteinprotein recognition sites. J. Biol. Chem. 265: 1602716030.
Jones, T.A., Zou, J.Y., Cowan, S.W., and Kjeldgaard, M. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47: 110119.
Katti, S.K., LeMaster, D.M., and Eklund, H. 1990. Crystal structure of thioredoxin from Escherichia coli at 1.68 Å resolution. J. Mol. Biol. 212: 167184.[CrossRef][Medline]
Kishigami, S., Akiyama, Y., and Ito, K. 1995. Redox states of DsbA in the periplasm of Escherichia coli. FEBS Lett. 364: 5558.[CrossRef][Medline]
Masip, L., Pan, J.L., Haldar, S., Penner-Hahn, J.E., DeLisa, M.P., Georgiou, G., Bardwell, J.C., and Collet, J.F. 2004. An engineered pathway for the formation of protein disulfide bonds. Science 303: 11851189.
Nikkola, M., Gleason, F.K., Fuchs, J.A., and Eklund, H. 1993. Crystal structure analysis of a mutant Escherichia coli thioredoxin in which lysine 36 is replaced by glutamic acid. Biochemistry 32: 50935098.[CrossRef][Medline]
Otwinowski, Z. and Minor, W. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276: 307326.
Rudresh, Jain, R., Dani, V., Mitra, A., Srivastava, S., Sarma, S.P., Varadarajan, R., and Ramakumar, S. 2002. Structural consequences of replacement of an
-helical Pro residue in Escherichia coli thioredoxin. Protein Eng. 15: 627633.
Schultz, L.W., Chivers, P.T., and Raines, R.T. 1999. The CXXC motif: Crystal structure of an active-site variant of Escherichia coli thioredoxin. Acta Crystallogr. D Biol. Crystallogr. 55: 15331538.[Medline]
Vagin, A. and Teplyakov, A. 2000. An approach to multi-copy search in molecular replacement. Acta Crystallogr. D Biol. Crystallogr. 56: 16221624.[CrossRef][Medline]
Zapun, A., Bardwell, J.C., and Creighton, T.E. 1993. The reactive and destabilizing disulfide bond of DsbA, a protein required for protein disulfide bond formation in vivo. Biochemistry 32: 50835092.[CrossRef][Medline]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |